Literature DB >> 3935668

Renal cortex taurine content regulates renal adaptive response to altered dietary intake of sulfur amino acids.

R W Chesney, N Gusowski, S Dabbagh.   

Abstract

Rats fed a reduced sulfur amino acid diet (LTD) or a high-taurine diet (HTD) demonstrate a renal adaptive response. The LTD results in hypotaurinuria and enhanced brush border membrane vesicle (BBMV) accumulation of taurine. The HTD causes hypertaurinuria and reduced BBMV uptake. This adaptation may relate to changes in plasma or renal cortex taurine concentration. Rats were fed a normal-taurine diet (NTD), LTD, or HTD for 14 d or they underwent: (a) 3% beta-alanine for the last 8 d of each diet; (b) 3 d of fasting; or (c) a combination of 3% beta-alanine added for 8 d and 3 d of fasting. Each maneuver lowered the cortex taurine concentration, but did not significantly lower plasma taurine values compared with controls. Increased BBMV taurine uptake occurred after each manipulation. Feeding 3% glycine did not alter the plasma, renal cortex, or urinary taurine concentrations, or BBMV uptake of taurine. Feeding 3% methionine raised plasma and urinary taurine excretion but renal tissue taurine was unchanged, as was initial BBMV uptake. Hence, nonsulfur-containing alpha-amino acids did not change beta-amino acid transport. The increase in BBMV uptake correlates with the decline in renal cortex and plasma taurine content. However, since 3% methionine changed plasma taurine without altering BBMV uptake, it is more likely that the change in BBMV uptake and the adaptive response expressed at the brush border surface relate to changes in renal cortex taurine concentrations. Finally, despite changes in urine and renal cortex taurine content, brain taurine values were unchanged, which suggests that this renal adaptive response maintains stable taurine concentrations where taurine serves as a neuromodulator.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3935668      PMCID: PMC424344          DOI: 10.1172/JCI112230

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  22 in total

Review 1.  Renal transport of amino acids.

Authors:  S Silbernagl; E C Foulkes; P Deetjen
Journal:  Rev Physiol Biochem Pharmacol       Date:  1975       Impact factor: 5.545

2.  Serum 5-nucleotidase.

Authors:  T F DIXON; M PURDOM
Journal:  J Clin Pathol       Date:  1954-11       Impact factor: 3.411

Review 3.  Renal tubular transport of amino acids.

Authors:  J A Young; B S Freedman
Journal:  Clin Chem       Date:  1971-04       Impact factor: 8.327

4.  The binding of D-glucose to the isolated luminal membrane of the renal proximal tubule.

Authors:  R W Chesney; B Sacktor; R Rowen
Journal:  J Biol Chem       Date:  1973-03-25       Impact factor: 5.157

5.  Analysis of Michaelis kinetics for two independent, saturable membrane transport functions.

Authors:  J L Neal
Journal:  J Theor Biol       Date:  1972-04       Impact factor: 2.691

6.  Renal transport of taurine adapts to perturbed taurine homeostasis.

Authors:  R Rozen; C R Scriver
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

7.  Renal adaptation to alteration in dietary amino acid intake.

Authors:  A L Friedman; P W Albright; N Gusowski; M Padilla; R W Chesney
Journal:  Am J Physiol       Date:  1983-08

8.  Development aspects of renal beta-amino acid transport II. Ontogeny of uptake and efflux processes and effect of anoxia.

Authors:  R W Chesney; D K Jax
Journal:  Pediatr Res       Date:  1979-07       Impact factor: 3.756

9.  Taurine mobilizing effects of beta alanine and other inhibitors of taurine transport.

Authors:  J E Shaffer; J J Kocsis
Journal:  Life Sci       Date:  1981-06-15       Impact factor: 5.037

10.  Renal brush border membrane adaptation to phosphorus deprivation: effects of fasting versus low-phosphorus diet.

Authors:  S A Kempson; S V Shah; P G Werness; T Berndt; P H Lee; L H Smith; F G Knox; T P Dousa
Journal:  Kidney Int       Date:  1980-07       Impact factor: 10.612

View more
  14 in total

1.  Taurine: A therapeutic agent in experimental kidney disease.

Authors:  H Trachtman; J A Sturman
Journal:  Amino Acids       Date:  1996-03       Impact factor: 3.520

2.  Taurine as osmoregulator and neuromodulator in the brain.

Authors:  S S Oja; P Saransaari
Journal:  Metab Brain Dis       Date:  1996-06       Impact factor: 3.584

3.  Renal adaptation to dietary amino acid alteration is expressed in immature renal brush border membranes.

Authors:  R W Chesney; N Gusowski; S Lippincitt; I Zelikovic
Journal:  Pediatr Nephrol       Date:  1988-01       Impact factor: 3.714

4.  Taurine transport in cultured choroid plexus.

Authors:  V K Ramanathan; S J Chung; K M Giacomini; C M Brett
Journal:  Pharm Res       Date:  1997-04       Impact factor: 4.200

Review 5.  The renal transport of taurine and the regulation of renal sodium-chloride-dependent transporter activity.

Authors:  R W Chesney; I Zelikovic; D P Jones; A Budreau; K Jolly
Journal:  Pediatr Nephrol       Date:  1990-07       Impact factor: 3.714

6.  Polarized nature of taurine transport in LLC-PK1 and MDCK cells: Further characterization of divergent transport models.

Authors:  D P Jones; R W Chesney
Journal:  Amino Acids       Date:  1993-10       Impact factor: 3.520

Review 7.  Renal amino acid transport: cellular and molecular events from clearance studies to frog eggs.

Authors:  R W Chesney; D Jones; I Zelikovic
Journal:  Pediatr Nephrol       Date:  1993-10       Impact factor: 3.714

8.  Efflux of taurine from renal brush border membrane vesicles: is it adaptively regulated?

Authors:  R W Chesney; A M Budreau
Journal:  Pediatr Nephrol       Date:  1993-02       Impact factor: 3.714

Review 9.  Taurine biosynthetic enzymes and taurine transporter: molecular identification and regulations.

Authors:  M L Tappaz
Journal:  Neurochem Res       Date:  2004-01       Impact factor: 3.996

10.  Taurine behaves as an osmolyte in Madin-Darby canine kidney cells. Protection by polarized, regulated transport of taurine.

Authors:  S Uchida; T Nakanishi; H M Kwon; A S Preston; J S Handler
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.